
Pharma Supply Chain
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight - from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage. von Rees
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
- paperback -
- Erschienen 2004
- Börm Bruckmeier
- Hardcover -
- Wiley John + Sons
- Hardcover
- 180 Seiten
- Erschienen 2001
- Govi
- Gebunden
- 1192 Seiten
- Erschienen 2021
- C.H.Beck
- paperback
- 460 Seiten
- Erschienen 2014
- C.H.Beck
- Hardcover
- 492 Seiten
- Erschienen 2005
- Springer
- paperback
- 614 Seiten
- Erschienen 2023
- C.H.Beck
- paperback
- 248 Seiten
- Erschienen 2008
- Gabler Verlag
- Kartoniert
- 320 Seiten
- Erschienen 2019
- Kogan Page
- hardcover
- 502 Seiten
- Erschienen 2010
- Wiley-VCH
- Kartoniert
- 248 Seiten
- Erschienen 2003
- Gabler Verlag